Lipella Pharmaceuticals Inc(LIPO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

LIPO Lipella Pharmaceuticals Inc

Closed 05-14 16:00:00 EDT

0.7500

+0.0173

+2.36%

盘后0.7639

+0.0139+1.85%

19:44 EDT

High0.7650	Low0.7350	Vol24.51K
Open0.7500	D1 Closing0.7327	Amplitude4.09%
Mkt Cap5.70M	Tradable Cap3.61M	Total Shares7.61M
T/O18.46K	T/O Rate0.51%	Tradable Shares4.81M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"LIPO","market":"US","secType":"STK","nameCN":"Lipella Pharmaceuticals Inc","latestPrice":0.75,"timestamp":1715716800000,"preClose":0.7327,"halted":0,"volume":24511,"hourTrading":{"tag":"盘后","latestPrice":0.7639,"preClose":0.75,"latestTime":"19:44 EDT","volume":153,"amount":116.8455,"timestamp":1715730285279},"delay":0,"floatShares":4810887,"shares":7605636,"eps":-0.742223,"marketStatus":"Closed","change":0.0173,"latestTime":"05-14 16:00:00 EDT","open":0.75,"high":0.765,"low":0.735,"amount":18457.6482383,"amplitude":0.040944,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.742223,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1715760000000},"marketStatusCode":5,"adr":0,"listingDate":1671512400000,"exchange":"NASDAQ","adjPreClose":0.7327,"postHourTrading":{"tag":"盘后","latestPrice":0.7639,"preClose":0.75,"latestTime":"19:44 EDT","volume":153,"amount":116.8455,"timestamp":1715730285279},"volumeRatio":1.934723},"requestUrl":"/m/hq/s/LIPO/tweets","defaultTab":"tweets","newsList":[{"id":"2428312537","title":"BRIEF-Lipella Pharmaceuticals Expands Its Advisory Board To Include Oncology Expertise","url":"https://stock-news.laohu8.com/highlight/detail?id=2428312537","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2428312537?lang=en_us&edition=fundamental","pubTime":"2024-04-17 20:15","pubTimestamp":1713356150,"startTime":"0","endTime":"0","summary":"April 17 (Reuters) - Lipella Pharmaceuticals Inc :   * LIPELLA PHARMACEUTICALS EXPANDS ITS ADVISORY BOARD TO INCLUDE ONCOLOGY EXPERTISESource text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2428314604","title":"Press Release: Lipella Pharmaceuticals Expands its Advisory Board to Include Oncology Expertise","url":"https://stock-news.laohu8.com/highlight/detail?id=2428314604","media":"Dow Jones","top":-1,"share":"https://ttm.financial/m/news/2428314604?lang=en_us&edition=fundamental","pubTime":"2024-04-17 20:00","pubTimestamp":1713355200,"startTime":"0","endTime":"0","summary":"The new oncology committee will include: Jason Hafron, MD, DDS, PhD, MPH; and Pradeep Tyagi, PhD, MBA. PITTSBURGH, Pa., April 17, 2024  -- Lipella Pharmaceuticals Inc.  , a clinical-stage biotechnology company, today announced the expansion of its Scientific Advisory Board to include oncology expertise.The new committee members are: Jason Hafron, MD, DDS, PhD, MPH, the Chief Medical Officer at Michigan Institute of Urology, and Professor of Urology at the William Beaumont School of Medicine; and Pradeep Tyagi, PhD, MBA, Professor of Urology, University of Pittsburgh School of Medicine, Pittsburgh, PA. Drs. Hafron and Tyagi have complementing expertise in both clinical and translational research in cancer treatment, with a focus on urologic oncology.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"gpt_icon":0},{"id":"2425545565","title":"Lipella Pharmaceuticals to Publish Abstract Detailing Compelling Preclinical Support for New Product Candidate at ASCO 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2425545565","media":"GlobeNewswire","top":-1,"share":"https://ttm.financial/m/news/2425545565?lang=en_us&edition=fundamental","pubTime":"2024-04-05 12:00","pubTimestamp":1712289600,"startTime":"0","endTime":"0","summary":"PITTSBURGH, April  05, 2024  (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (NASDAQ: LIPO) (“Lipella,” “our”, “us” or the “Company”), a clinical-stage biotechnology company addressing serious diseas","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/04/05/2858476/0/en/Lipella-Pharmaceuticals-to-Publish-Abstract-Detailing-Compelling-Preclinical-Support-for-New-Product-Candidate-at-ASCO-2024.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2424810523","title":"BRIEF-Lipella Pharmaceuticals Announces FDA Type C Meeting For LP-10 For Hemorrhagic Cystitis","url":"https://stock-news.laohu8.com/highlight/detail?id=2424810523","media":"Reuters","top":-1,"share":"https://ttm.financial/m/news/2424810523?lang=en_us&edition=fundamental","pubTime":"2024-04-03 20:44","pubTimestamp":1712148247,"startTime":"0","endTime":"0","summary":"April 3  - Lipella Pharmaceuticals Inc :   * LIPELLA PHARMACEUTICALS ANNOUNCES FDA TYPE C MEETING FOR LP-10 FOR HEMORRHAGIC CYSTITIS   * LIPELLA PHARMACEUTICALS -  FDA GRANTED TYPE C MEETING REQUEST TO DISCUSS CO'S PROPOSED PHASE-2B CLINICAL TRIAL DESIGN FOR EVALUATION OF LP-10   * LIPELLA PHARMACEUTICALS INC - EXPECTS TO MEET WITH FDA ON MAY 21Source text for Eikon:    Further company coverage:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2424177618","title":"Lipella announces FDA type C meeting for its hemorrhagic cystitis treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2424177618","media":"seekingalpha","top":-1,"share":"https://ttm.financial/m/news/2424177618?lang=en_us&edition=fundamental","pubTime":"2024-04-03 20:38","pubTimestamp":1712147904,"startTime":"0","endTime":"0","summary":"Lipella Pharmaceuticals  announced that the FDA has granted a Type C meeting request to discuss the company’s proposed Phase-2b clinical trial design for the evaluation of LP-10 as a potential treatment for moderate to severe hemorrhagic cystitis.Lipella expects to meet with the FDA on May 21, 2024. Source: Press Release","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4086725-lipella-announces-fda-type-c-meeting-for-its-hemorrhagic-cystitis-treatment","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.lipella.com","stockEarnings":[{"period":"1week","weight":-0.0139},{"period":"1month","weight":0.0542},{"period":"3month","weight":-0.2599},{"period":"6month","weight":-0.3516},{"period":"1year","weight":-0.6038},{"period":"ytd","weight":-0.2817}],"compareEarnings":[{"period":"1week","weight":0.0084},{"period":"1month","weight":0.0197},{"period":"3month","weight":0.0543},{"period":"6month","weight":0.1584},{"period":"1year","weight":0.2656},{"period":"ytd","weight":0.0959}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Lipella Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. It is developing LP-10, a formulation of tacrolimus that is in Phase IIa clinical trial for patients with radiation-induced hemorrhagic cystitis; and LP-310, a formulation of tacrolimus for the treatment of oral lichen planus. Lipella Pharmaceuticals Inc. was incorporated in 2005 and is based in Pittsburgh, Pennsylvania.","exchange":"NASDAQ","name":"Lipella Pharmaceuticals Inc","nameEN":"Lipella Pharmaceuticals Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Lipella Pharmaceuticals Inc(LIPO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Lipella Pharmaceuticals Inc(LIPO) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Lipella Pharmaceuticals Inc,LIPO,Lipella Pharmaceuticals Inc股票,Lipella Pharmaceuticals Inc股票老虎,Lipella Pharmaceuticals Inc股票老虎国际,Lipella Pharmaceuticals Inc行情,Lipella Pharmaceuticals Inc股票行情,Lipella Pharmaceuticals Inc股价,Lipella Pharmaceuticals Inc股市,Lipella Pharmaceuticals Inc股票价格,Lipella Pharmaceuticals Inc股票交易,Lipella Pharmaceuticals Inc股票购买,Lipella Pharmaceuticals Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Lipella Pharmaceuticals Inc(LIPO),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Lipella Pharmaceuticals Inc(LIPO) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction